GlassScriptPhysician profile
Melissa A Wallace
NPI 1023524501
$4,305.58
in general payments reported to CMS, 2019-2025
23 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $905 · 2022: $882 · 2023: $1,162 · 2024: $943 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,319 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,319.07 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,309.12 | 2021-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $542.67 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $441.00 | 2021-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $439.82 | 2021-2025 | |
| Urogen Pharma, INC. | $193.64 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $155.04 | 2021-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $141.36 | 2022-2025 | Keytruda, Lynparza |
| Astrazeneca Pharmaceuticals LP | $130.07 | 2021-2024 | Lynparza |
| Coloplast Corp | $115.93 | 2021-2022 | |
| Axonics, INC. | $100.26 | 2023-2024 | Axonics, Bulkamid |
| Pfizer INC. | $95.49 | 2022-2025 | |
| Convatec INC. | $89.78 | 2023-2024 | |
| Urovant Sciences INC | $88.16 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $76.46 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $66.04 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $62.75 | 2024 | |
| Karl Storz Endoscopy-America | $58.39 | 2022-2023 | N.A. |
| Bayer Healthcare Pharmaceuticals INC. | $46.04 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $42.82 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $37.49 | 2023-2024 | |
| C. R. Bard, INC. & Subsidiaries | $29.16 | 2023 | Bard Urinary Drainage Bag |
| Olympus America INC. | $24.51 | 2023 | Itind System |
| Procept Biorobotics Corporation | $19.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.